AiCure

CROs/Service Providers

PPD acquires X-Chem

Tuesday, October 7, 2014 10:30 AM

Pharmaceutical Product Development (PPD), a Wilmington, N.C.-based CRO, has exercised its option to acquire the remaining minority ownership interest of X-Chem. X-Chem, a biotechnology company based in Waltham, Mass., will continue to operate as a biotechnology company with its entire existing staff, including its management team led by CEO and founder Richard W. Wagner, Ph.D., along with executive management team members Diala Ezzeddine, Ph.D., chief business officer; Matthew Clark, Ph.D., sr. vice president of research; and Lee Babiss as chairman of the board.

More... »


Bracket names Jeff Kinell CEO

Monday, October 6, 2014 06:54 AM

Bracket, a clinical trial specialty services provider, has announced the addition of Jeffrey W. Kinell as CEO and new member of its board of directors.

More... »

Subscribe to The CenterWatch Monthly

Parexel International acquires ClinIntel

Friday, October 3, 2014 10:58 AM

Global CRO Parexel International, headquartered in Waltham, Mass., has acquired privately-owned ClinIntel, a provider of clinical Randomization and Trial Supply Management (RTSM) services, based in Crawley, U.K.

More... »

NCI co-funding Pharmatech Just-In-Time expansion

Thursday, October 2, 2014 02:13 PM

The National Cancer Institute (NCI) is co-funding Denver, Colo.-based CRO Pharmatech’s development of AccessPPM and expansion of its Just-In-Time enrollment programs.

More... »

Horizon Discovery Group acquires Sage Labs for $48M

Wednesday, October 1, 2014 01:18 PM

Horizon Discovery Group, a Cambridge, U.K.-based international life science company supplying research tools and services to organizations engaged in genomics research and the development of personalized medicines, has agreed to acquire Sage Labs, a St. Louis, Mo.-based provider of advanced in vivo transgenic disease models for use in preclinical research, for up to $16 million in cash and up to $32 million through the issue of new ordinary shares.

More... »

LabConnect uses custom approach to enhance clinical data mining

Wednesday, October 1, 2014 01:16 PM

LabConnect, a Seattle, Wash.-based provider of central laboratory services to the biopharmaceutical industry, has released its BioVisualization software platform.

More... »

WuXi PharmaTech acquires XenoBiotic Laboratories

Wednesday, October 1, 2014 01:11 PM

CRO WuXi PharmaTech, with operations in China and the U.S., has acquired XenoBiotic Laboratories (XBL), a CRO with facilities in New Jersey and China. Financial terms have not been disclosed.

More... »

Consort Medical to acquire Aesica Pharmaceuticals for $373 million

Wednesday, October 1, 2014 01:08 PM

Consort Medical is acquiring Aesica Pharmaceuticals for $373 million. The closing of the transaction, expected to occur in November, is conditional on the approval of Consort Medical’s shareholders and clearance by the German competition authorities.

More... »

Chiltern acquires Pacific Clinical Research, expands in Asia-Pacific

Monday, September 29, 2014 01:24 PM

Chiltern, a global clinical CRO, has acquired Pacific Clinical Research, a pan-Asian CRO based in Singapore. The move allows Chiltern to offer integrated services throughout the Asia-Pacific region and strengthens its oncology and anti-infective offerings.

More... »

Pharma & Biopharma Outsourcing Association formed

Monday, September 29, 2014 01:14 PM

Fifteen contract manufacturing organizations and contract development and manufacturing organizations (CMOs/CDMOs) have joined the Pharma & Biopharma Outsourcing Association (PBOA), a new nonprofit trade association that aims to help advance the industry's regulatory, legislative and business interests. 

More... »


CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

November 17

PPD, Medidata join their technologies for risk-based monitoring, adaptive trial design

ERT acquires eClinical Insights in "strategic combination" to gain cloud-based trial software platform, expertise

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

November

Private equity driving dynamic CRO growth
Enables CROs to pursue long-term strategies, while giving the space credibility

Baby boomers poised to reshape clinical trials industry
Millions of tech-savvy consumers already track their health, expect new treatments as they age

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

October

CROs driving changes in patient recruitment
Data- and tech-aided enrollment services a competitive advantage

Trials with in-home nurses poised to grow
Higher expense, but may improve recruitment and retention for select trials

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs